Statement of the Austrian Society of Pneumology (ASP)

The COVID-19 pandemic is currently a challenge worldwide. In Austria, a crisis within the health care system has so far been avoided. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines durin...

Full description

Saved in:
Bibliographic Details
Published inWiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift p. 1
Main Authors Flick, H, Arns, B M, Bolitschek, J, Bucher, B, Cima, K, Gingrich, E, Handzhiev, S, Hochmair, M, Horak, F, Idzko, M, Jaksch, P, Kovacs, G, Kropfmüller, R, Lamprecht, B, Löffler-Ragg, J, Meilinger, M, Olschewski, H, Pfleger, A, Puchner, B, Puelacher, C, Prior, C, Rodriguez, P, Salzer, H, Schenk, P, Schindler, O, Stelzmüller, I, Strenger, V, Täubl, H, Urban, M, Wagner, M, Wimberger, F, Zacharasiewicz, A, Zwick, R H, Eber, E
Format Journal Article
LanguageGerman
Published Austria 18.05.2020
Subjects
COVID-19
Chronic lung diseases
SARS-CoV‑2
Community-acquired pneumonia
ARDS
Online AccessGet full text

Cover

More Information
Summary:The COVID-19 pandemic is currently a challenge worldwide. In Austria, a crisis within the health care system has so far been avoided. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic. However, COVID-19-specific adjustments are useful. The treatment of patients with chronic lung diseases must be adapted during the pandemic, but must still be guaranteed.
ISSN:1869-1757